Zika Update

Researchers in Brazil ponder whether virus alone causes birth defects; Colombia declares epidemic over; first Zika-related microcephaly case reported in Europe

Written byTanya Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Distribution of Zika virus infections (past and present)WIKIMEDIA, FURFURZika virus infection has been linked to birth defects, but nearly 90 percent of the reported microcephaly cases have been confined to a northeastern region of Brazil. The geographic concentration of Zika-related birth defects has some experts wondering whether other factors may be at play, Nature News reported yesterday (July 25).

“We suspect that something more than Zika virus is causing the high intensity and severity of cases,” Fatima Marinho, director of information and health analysis at Brazil’s ministry of health, told Nature.

One possible explanation is socioeconomic—most of the mothers who have given birth to babies with microcephaly tend to be young, black, poor, and live in or near cities, according to Marinho. Another possibility is co-infection with other viruses, such as dengue or chikungunya. A third is low vaccination rates for yellow fever. Until researchers know more, public health experts should exercise precaution, virologist Ian Lipkin of Columbia University in New York City told Nature.

Meanwhile, health officials in Colombia announced yesterday that the outbreak there is over, STAT News reported. Although new cases ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies